HCA

HCA Healthcare, Inc.

NYSE: HCA · HEALTHCARE · MEDICAL CARE FACILITIES

$426.37

+2.85% today

Updated 2026-06-05

Market cap

$80.58B

P/E ratio

12.52

P/S ratio

1.06x

EPS (TTM)

$29.02

Dividend yield

0.80%

52W range

$328 – $556

Volume

1.3M

Market cap

$80.58B

P/E ratio

12.52

P/S ratio

1.06x

EPS (TTM)

$29.02

Dividend yield

0.80%

52W range

$328 – $556

Volume

1.3M

HCA Healthcare, Inc. (HCA) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

HCA · HCA Healthcare, Inc. · Price target summary

Current

$426.37

Consensus

$528.00

+23.84%

2030 Target

$5,143.06

+1106.24%

DCF

$286.26

-85.66% MoS

Current price

$426.37

Analyst consensus

$528.00

+23.84%

2030 Target

$5,143.06

+1106.24%

Intrinsic (DCF)

$286.26

-85.66% MoS

21 analysts:

13 Buy7 Hold1 Sell

Management guidance

No specific CEO revenue guidance found in available data. Management has not provided explicit revenue targets for 2026-2030 period. Company guidance focuses on operational metrics (patient volumes, margin improvement) rather than absolute revenue figures.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

HCA · HCA Healthcare, Inc. · Revenue & price projection · 2023–2030E

Actual revenue Projected revenue Base case Bull to bear range

Bear case (2030)

$3,444.43

$96.5B Rev × 8x P/S

Base case (2030)

$5,143.06

$96.5B Rev × 12x P/S

Bull case (2030)

$8,587.49

$96.5B Rev × 20x P/S

WallStSmart.com

Financial forecast — research-backed

Metric	2025	2026 (E)	2027 (E)	2028 (E)	2029 (E)	2030 (E)
Revenue	$75.6B	$79.4B	$83.3B	$87.5B	$91.8B	$96.5B
Revenue growth	7.1%	5.1%	4.9%	5.0%	5.0%	5.1%
EPS	$28.39	$30.53	$33.67	$36.50	$39.50	$42.75
P/S ratio	—	12.0x	12.0x	12.0x	12.0x	12.0x
Implied price	—	$4,246.56	$4,435.30	$4,671.22	$4,907.14	$5,143.06

HCA · HCA Healthcare, Inc. · Catalysts & risks

Growth catalysts

+ Aging US population (65+ demographic expanding 3-4% annually)

+ Strategic M&A and de novo hospital/ASC expansions in high-growth states

+ Technology investments and AI/Palantir integration for operational efficiency

+ Market consolidation benefits (scale advantages vs peers)

+ Margin expansion from labor productivity improvements

Key risks

- Medicaid reimbursement pressures and ACA subsidy uncertainties ($250M+ annual impact potential)

- Labor cost inflation and nursing shortages limiting margin growth

- High debt levels (~$156B enterprise value) limiting financial flexibility

- Regulatory/political risk to hospital margins and reimbursement models

- Economic recession reducing elective procedures and patient volumes

Methodology

HCA Healthcare, Inc.'s forward estimates are derived from AI-powered research synthesis combining analyst consensus from 21 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.